Bu-b Activators
Bu-b Activators are a series of chemical compounds that indirectly facilitate the functional activation of Bu-b through a variety of specific intracellular signaling pathways. Forskolin and Isoproterenol, by virtue of their capacity to raise intracellular cAMP levels, are presumed to activate protein kinase A (PKA), which in turn could phosphorylate and enhance the activity of Bu-b if it is part of the cAMP/PKA signaling axis. Epigallocatechin gallate (EGCG) and Genistein, through their actions as kinase inhibitors, may lift the repressive phosphorylation events on Bu-b, provided that Bu-b's activity is regulated by such kinases. Phorbol 12-myristate 13-acetate (PMA), acting as a potent activator of protein kinase C (PKC), could exert an enhancing effect on Bu-b if it is a PKC substrate or is modulated by pathways under PKC control. Sphingosine-1-phosphate (S1P), through its receptor-mediated signaling, could also augment the activity of Bu-b by initiating signaling cascades related to cell survival and proliferation that involve Bu-b.
The modulation of Bu-b activity extends to the influence of intracellular calcium dynamics, as exemplified by ionomycin, thapsigargin, and A23187, all of which increase the cytosolic calcium concentration. If Bu-b's activity is modulated by calcium-calmodulin kinases or is embedded within calcium-dependent signaling networks, these ionophores can act as indirect activators. The PI3K pathway inhibitor LY294002, MEK inhibitors U0126, and p38 MAPK inhibitor SB203580 may also play a role in enhancing Bu-b activity by lifting negative regulation imposed by these pathways. This multifaceted approach to enhancing Bu-b's functional activity through indirect activation illustrates the complexity of intracellular signaling and the potential for cross-talk between various pathways that converge on the regulation of Bu-b.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin acts by activating the enzyme adenylyl cyclase, leading to increased levels of cyclic AMP (cAMP) within cells. Elevated cAMP can activate protein kinase A (PKA), which may then phosphorylate and enhance the activity of Bu-b if Bu-b is a downstream effector in the cAMP/PKA signaling pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain types of kinases. If Bu-b activity is suppressed by a kinase that is inhibited by EGCG, then inhibition of this kinase could enhance the activity of Bu-b by reducing its phosphorylation-dependent suppression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). If Bu-b is a substrate of PKC or is part of a pathway regulated by PKC, PMA could enhance its activity through PKC-mediated signaling events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) binds to S1P receptors, activating intracellular signaling cascades that could lead to the activation of Bu-b if it is part of these pathways, particularly those related to cell survival and proliferation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting calcium-dependent proteins. If Bu-b is activated by calcium/calmodulin-dependent kinases or is part of calcium-regulated pathways, ionomycin could enhance its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic agonist that elevates intracellular cAMP levels, similar to forskolin. It could enhance the activity of Bu-b through the cAMP/PKA signaling cascade if Bu-b is influenced by this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of the phosphatidylinositol 3-kinase (PI3K) pathway. If the activity of Bu-b is negatively regulated by PI3K or downstream effectors like AKT, inhibition by LY294002 could lead to enhancement of Bu-b activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, key enzymes in the MAPK/ERK pathway. If Bu-b is suppressed by the MAPK/ERK pathway, inhibition by U0126 might enhance the activity of Bu-b by disrupting this suppressive signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. If Bu-b operates downstream or is regulated by the p38 MAPK pathway, inhibition by SB203580 could relieve negative regulation and enhance the activity of Bu-b. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels. If Bu-b is part of or regulated by calcium signaling pathways, thapsigargin could indirectly enhance its activity. | ||||||